125 related articles for article (PubMed ID: 12127553)
1. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia.
Goller ME; Kneitz C; Mehringer C; Müller K; Jelley-Gibbs DM; Gosselin EJ; Wilhelm M; Tony HP
Leuk Res; 2002 Sep; 26(9):795-802. PubMed ID: 12127553
[TBL] [Abstract][Full Text] [Related]
2. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
Sarfati M; Fournier S; Christoffersen M; Biron G
Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
[TBL] [Abstract][Full Text] [Related]
4. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts.
Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M
Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.
Giordano Attianese GM; Marin V; Hoyos V; Savoldo B; Pizzitola I; Tettamanti S; Agostoni V; Parma M; Ponzoni M; Bertilaccio MT; Ghia P; Biondi A; Dotti G; Biagi E
Blood; 2011 May; 117(18):4736-45. PubMed ID: 21406718
[TBL] [Abstract][Full Text] [Related]
6. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
[TBL] [Abstract][Full Text] [Related]
7. Differential T cell-mediated regulation of CD23 (Fc epsilonRII) in B cells and follicular dendritic cells.
Sukumar S; Conrad DH; Szakal AK; Tew JG
J Immunol; 2006 Apr; 176(8):4811-7. PubMed ID: 16585575
[TBL] [Abstract][Full Text] [Related]
8. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel FcepsilonRII/CD23 isoforms lacking the transmembrane (TM) segment in human cell lines.
Yoshikawa T; Matsui M; Gon Y; Yoshioka T; Hirama M; Lynch RG; Naito K; Yodoi J
Mol Immunol; 1999 Dec; 36(18):1223-33. PubMed ID: 10684962
[TBL] [Abstract][Full Text] [Related]
10. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.
Kriston C; Bödör C; Szenthe K; Bánáti F; Bánkuti B; Csernus B; Reiniger L; Csomor J; Matolcsy A; Barna G
Hematol Oncol; 2017 Mar; 35(1):58-63. PubMed ID: 26119874
[TBL] [Abstract][Full Text] [Related]
11. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
Gu B; Bendall LJ; Wiley JS
Blood; 1998 Aug; 92(3):946-51. PubMed ID: 9680363
[TBL] [Abstract][Full Text] [Related]
12. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
13. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathology of chronic lymphocytic leukemia disease.
Sarfati M
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):109-13. PubMed ID: 8332446
[TBL] [Abstract][Full Text] [Related]
15. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and B-chronic lymphocytic leukemia.
Koiso H; Tsukamoto N; Miyawaki S; Shinonome S; Nojima Y; Karasawa M
Leuk Res; 2002 Sep; 26(9):809-15. PubMed ID: 12127555
[TBL] [Abstract][Full Text] [Related]
18. The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes.
Ewart MA; Ozanne BW; Cushley W
Genes Immun; 2002 May; 3(3):158-64. PubMed ID: 12070780
[TBL] [Abstract][Full Text] [Related]
19. Pax-5 is a key regulator of the B cell-restricted expression of the CD23a isoform.
Visan I; Goller M; Berberich I; Kneitz C; Tony HP
Eur J Immunol; 2003 May; 33(5):1163-73. PubMed ID: 12731041
[TBL] [Abstract][Full Text] [Related]
20. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
